EGFR and neoplasm: Epidermal growth factor receptor (EGFR), a member of the ErbB receptor tyrosine kinase family, contains tumor-specific epitopes within its extracellular domain and is mutated or overexpressed in over 60% of NSCLC cases, promoting tumor proliferation and metastasis (70).